Investor RelationsWelcome to the Investor Relations section of the Cynapsus Therapeutics website. This area is dedicated to keeping shareholders and potential investors up to date with detailed and accurate information. Investor AlertsTo receive email alerts of future company announcments contact us at [email protected] Link to EDGARCynapsus' public securities documents and information can be found on EDGAR at Link to SEDARCynapsus' public securities documents and information can be found on SEDAR at http://www.sedar.com/search/search_form_pc_en.htm
|
2015 CalendarKey DatesCowen & Co. 36th Annual Health Care Conference YE 2015 Results Annual General Meeting of the Shareholders Q1 2016 Results Q2 2016 Results Q3 2016 Results 2016 Financial Year End
Analyst CoverageBank of America Merrill Lynch, Initiation of Coverage (Jul 2015) – Sumant S. Kulkarni ([email protected]) Nomura, Initiation of Coverage (Jul 2015) – Do Kim ([email protected]) Noble Financial, Initiation of Coverage (Jul 2013) - Nathan Cali ([email protected]) M Partners, Initiation of Coverage (Jan 2014) - Daniel Pearlstein ([email protected]) Rx Securities, Initiation of Coverage (Nov 2015) – Dr. Samir Devani ([email protected]) Cynapsus is followed by the research analysts listed. Please note that any opinions, estimates, or forecasts regarding Cynapsus’ performance made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions of Cynapsus or its management. Cynapsus does not, by its reference or distribution, imply its endorsement of, or concurrence with, such information, conclusions, or recommendations. Cynapsus does not provide analyst reports to persons outside of the company. Please contact the research analyst directly to obtain a report. PFIC StatementsClick to download the 2015 PFIC Annual Information Statement Click to download the 2014 PFIC Annual Information Statement |